Printer Friendly

Articles from Chain Drug Review (September 25, 1989)

1-36 out of 36 article(s)
Title Author Type Words
AADS accepts resignation of Weinstein. 464
AADS plans changes at shows: will expand membership. 545
AARP maps prices of brands, generics. 545
Albertson's performance impressive. 394
Big B sales surging after Reed buy-out. 329
Black hair care outlook bright. 458
Chain drug stocks post a decline in August. 898
Chains trying new techniques: market their treatment lines. 549
Cosmetics firms debut specialty lines. 938
Coutu to buy 12 Cloutier units. Sinisi, John 508
Drug chains detail the nail care trends. 571
Drug Emporium tenders offering to garner funds. 353
Eckerd, Wal-Mart end deal with Blue Cross. Greco, Matthew 688
False nails will benefit from intros. 745
FDA is banning hair restorers: cosmetic claims unaffected. 743
Field resigns top position at McKesson. 546
Giant Food net, volume rise for qtr. 307
H&BA houses release plethora of skin treatment lines. 797
Hair care mfrs. strike blow versus diverters. 900
Hairbrush competition hotter. 884
Harris and R.A.B. elevate two. 302
Long-wearing color to bolster enamels. 864
Medicap program targets public health awareness. 277
Nail care registers steady gains. 440
Perry is registering gains via its continuing operations. 434
Phar-Mor slates Detroit for rapid expansion. 277
Revco appoints executives for loss prevention, audit. 319
Rx conference reflects the importance of NACDS. Pinto, David column 505
Rx meeting focuses on Medicare issues. 503
SGC names Futterman as chairman. 221
Shampoos, conditioners buzz with activity in 1989. 1331
Skin care sales pace toiletries. 386
Study maps supermarket polish sales. 210
Super Rite divestiture draws nigh. 355
Thrifty White conversion set to unite outlets under one name. 215
Two mergers spur competition: form formidable alliances. 397

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters